Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus D Flather

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
American Heart Journal|June 23, 2007
Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trialDaniela Dobre, Dirk J van Veldhuisen, Giacomo Mordenti, et al.
American Heart Journal|October 11, 2011
Cluster-randomized trial to evaluate the effects of a quality improvement program on management of non-ST-elevation acute coronary syndromes: The European Quality Improvement Programme for Acute Coronary Syndromes (EQUIP-ACS)Marcus D Flather, Daphne Babalis, Jean Booth, et al.
Disease Markers|August 1, 2012
Paraoxonase-1 is not associated with coronary artery calcification in type 2 diabetes: results from the PREDICT studyBharti Mackness, Judit Marsillach, Robert S Elkeles, et al.
The American Journal of Medicine|July 6, 2004
Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational studyKim A Eagle, Eva Kline-Rogers, Shaun G Goodman, et al.
Journal of the American College of Cardiology|June 6, 2009
Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure)Dirk J van Veldhuisen, Alain Cohen-Solal, Michael Böhm, et al.
Trials|January 16, 2010
Improving the management of non-ST elevation acute coronary syndromes: systematic evaluation of a quality improvement programme European QUality Improvement Programme for Acute Coronary Syndrome: the EQUIP-ACS project protocol and designMarcus D Flather, Jean Booth, Daphne Babalis, et al.
European Heart Journal|August 12, 2003
From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE)Keith A A Fox, Shaun G Goodman, Frederick A Anderson, et al.
Trials|June 17, 2017
Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trialPeter Saunders, Vicky Tsipouri, Gregory J Keir, et al.
Journal of Clinical Neurology (Seoul, Korea)|November 8, 2016
A 6-Point TACS Score Predicts In-Hospital Mortality Following Total Anterior Circulation StrokeAdrian D Wood, Nicholas D Gollop, Joao H Bettencourt-Silva, et al.
The American Journal of Cardiology|July 9, 2010
Influence of diabetes mellitus and hyperglycemia on prognosis in patients > or =70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS])Rudolf A de Boer, Wolfram Doehner, Iwan C C van der Horst, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
American Heart Journal|June 23, 2007
Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trialDaniela Dobre, Dirk J van Veldhuisen, Giacomo Mordenti, et al.
American Heart Journal|October 11, 2011
Cluster-randomized trial to evaluate the effects of a quality improvement program on management of non-ST-elevation acute coronary syndromes: The European Quality Improvement Programme for Acute Coronary Syndromes (EQUIP-ACS)Marcus D Flather, Daphne Babalis, Jean Booth, et al.
Disease Markers|August 1, 2012
Paraoxonase-1 is not associated with coronary artery calcification in type 2 diabetes: results from the PREDICT studyBharti Mackness, Judit Marsillach, Robert S Elkeles, et al.
The American Journal of Medicine|July 6, 2004
Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational studyKim A Eagle, Eva Kline-Rogers, Shaun G Goodman, et al.
Journal of the American College of Cardiology|June 6, 2009
Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure)Dirk J van Veldhuisen, Alain Cohen-Solal, Michael Böhm, et al.
Trials|January 16, 2010
Improving the management of non-ST elevation acute coronary syndromes: systematic evaluation of a quality improvement programme European QUality Improvement Programme for Acute Coronary Syndrome: the EQUIP-ACS project protocol and designMarcus D Flather, Jean Booth, Daphne Babalis, et al.
European Heart Journal|August 12, 2003
From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE)Keith A A Fox, Shaun G Goodman, Frederick A Anderson, et al.
Trials|June 17, 2017
Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trialPeter Saunders, Vicky Tsipouri, Gregory J Keir, et al.
Journal of Clinical Neurology (Seoul, Korea)|November 8, 2016
A 6-Point TACS Score Predicts In-Hospital Mortality Following Total Anterior Circulation StrokeAdrian D Wood, Nicholas D Gollop, Joao H Bettencourt-Silva, et al.
The American Journal of Cardiology|July 9, 2010
Influence of diabetes mellitus and hyperglycemia on prognosis in patients > or =70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS])Rudolf A de Boer, Wolfram Doehner, Iwan C C van der Horst, et al.
Pageof 8